The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Icosavax(NASDAQ:ICVX) 
Icosavax, Inc., a biopharmaceutical company, develops vaccines against infectious diseases. The company, with the help of its virus-like particle (VLP) platform technology, focuses primarily on life-threatening respiratory diseases. Its products in pipeline include IVX-A12, an respiratory syncytial ...
Website: https://icosavax.com/
Founded: 2017
CEO: Adam Simpson
Sector: Healthcare
Industry: Biotechnology
Icosavax Number of Twitter Followers
Icosavax Days Payable Outstanding ttm (DPO)
Icosavax Op Cashflow Per Share ttm
Icosavax Free Cashflow Per Share ttm
Icosavax Cash Per Share ttm
Icosavax P/S ratio ttm
Icosavax (GAAP) P/E ratio ttm
Icosavax P/B ratio ttm
No extra charts and metrics for this ticker.